Comparison of DNA adduct levels associated with oxidative stress in human pancreas

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 405, Issue 2, 1998, Pages 125-133

  Kadlubar, F F ^a   Anderson, K E ^b   Haussermann S ^c   Lang, N P ^d,e   Barone, G W ^d,f   Thompson, P A ^a   MacLeod, S L ^e   Chou, M W ^a   Mikhailova, M ^a   Plastaras, J ^g   Marnett, L J ^g   Nair, J ^c   Velic, I ^c   Bartsch, H ^c  

^a US FDA Natl Ctr Toxicological R   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d John L McClellan Mem Med Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

8 Oxo 2' deoxyguanosine; DNA adduct; Etheno adduct; Glutathione S transferase; Human pancreas; Malondialdehyde adduct; Quinone reductase

Indexed keywords

1,N6 ETHENO 2' DEOXYGUANOSINE; 3,N4 ETHENO 2' DEOXYCYTIDINE; 8 OXO 2 DEOXYGUANOSINE; GLUTATHIONE TRANSFERASE; NUCLEOTIDE; PYRIMIDO[1,2 ALPHA]PURIN 10(3H) ONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; CHILD; CYTIDINE; DEOXYGUANOSINE; DNA ADDUCTS; FEMALE; GLUTATHIONE TRANSFERASE; GUANINE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; PANCREAS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PURINES; PYRIMIDINES; SMOKING;

EID: 2042492994     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00129-8     Document Type: Conference Paper

References (27)

1. [1] S. Loft, H.E. Poulsen, Cancer risk and oxidative DNA damage in man, J. Mol. Med. 74 (1996) 297-312.
2. [2] F.-L. Chung, H.-Y.C. Chen, R.G. Nath, Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts, Carcinogenesis 17 (1996) 2105-2111.
3. [3] J. Nair, C.E. Vaca, I. Velic, M. Mutanen, L.M. Valsta, H. Bartsch, High dietary ω-6 polyunsaturated fatty acids drastically increase the formation of etheno adducts in white blood cells of female subjects, Cancer Epidemiol., Biomarkers Prev. 6 (1997) 597-601.
4. [4] S.P. Fink, G.R. Reddy, L.J. Marnett, Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8652-8657.
5. [5] J.A. Swenberg, D.K. La, N.A. Scheller, K.Y. Wu, Dose-response relationship for carcinogens, Toxicol. Lett. 82-83 (1995) 751-756.
6. [6] M. Wang, K. Dhingra, W.N. Hittelman, J.G. Liehr, M. de Andrade, D. Li, Lipid peroxidation-induced malondialdehyde adducts in human breast tissues, Cancer Epidemiol. Biomarkers Prev. 5 (1996) 705-710.
7. [7] S.-C. Baik, H.-S. Youn, M.-H. Chung, W.-K. Lee, M.-J. Cho, G.-H. Ko, C.-K. Park, H. Kasai, K.-H. Rhee, Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa, Cancer Res. 56 (1996) 1279-1282.
8. [8] S. Asami, H. Manabe, J. Miyake, Y. Tsurodome, T. Hirano, R. Yamaguchi, H. Itoh, H. Kasai, Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung, Carcinogenesis 18 (1997) 1763-1766.
9. [9] B. Marczynski, P. Rozynek, H.-J. Elliehausen, M. Korn, X. Bauer, Detection of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, in white blood cells of workers occupationally exposed to styrene, Arch. Toxicol. 71 (1997) 496-500.
10. [10] H. Daube, G. Scherer, K. Riedel, T. Ruppert, A.R. Tricker, P. Rosenbaum, F. Adlkofer, DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status, J. Cancer Res. Clin. Oncol. 123 (1997) 141-151.
11. [11] P.C. Dedon, J.P. Plastaras, C.A. Rouzer, L.J. Marnett, Indirect mutagenesis by oxidative damage: formation of a pyrimidopurine adduct by base propenals. Chem. Res. Tox., in press.
12. [12] A. Collins, J. Cadet, B. Epe, C. Gedik, Problems in the measurement of 8-oxoguanine in human DNA. Report of a workshop, DNA Oxidation, held in Aberdeen, UK, 19-21 January, 1997, Carcinogenesis, 18, 1997, 1833-1836.
13. [13] Pancreas, in Food, Nutrition and the Prevention of Cancer: a Global Perspective, Chap. 4.7, World Cancer Research Fund/American Institute for Cancer Research, Washington D.C., 1997, pp. 176-197.
14. [14] K.E. Anderson, J.D. Potter, T. Mack, Pancreas cancer, in: D. Schottenfeld, J.F. Fraumeni, Jr. (Eds.), Cancer Epidemiology and Prevention, 2nd edn., Oxford University Press, New York, 1996, pp. 725-771.
15. [15] K.E. Anderson, G.J. Hammons, F.F. Kadlubar, J.D. Potter, K.R. Kaderlik, K.F. Ilett, R.F. Minchin, C.H. Teitel, H.-C. Chou, M.V. Martin, P.P. Guengerich, G.W. Barone, N.P. Lang, L.A. Peterson, Metabolic activation of aromatic amines by human pancreas, Carcinogenesis 18 (1997) 1085-1092.
16. [16] F.O. Belzer, J.H. Southard, Principles of solid-organ preservation by cold storage, Transplantation 45 (1988) 673-676.
17. [17] R.C. Gupta, Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo, Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 6943-6947.
18. [18] K. Burton, Determination of DNA concentration with diphenylamine, Methods Enzymol. 12B (1968) 163-169.
19. [19] M.V. Mikhailova, N.A. Littlefield, B.S. Mass, L.A. Poirier, M.W. Chou, Cadmium-induced 8-hydroxyguanosine formation, DNA strand breaks and antioxidant enzyme activities in lymphoblastoid cells, Cancer Lett. 115 (1997) 141-148.
20. [20] C.A. Rouzer, A.K. Chaudhary, M. Nokubo, D.M. Ferguson, G.R. Reddy, I.A. Blair, L.J. Marnett, Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurine in human leucocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry, Chem. Res. Tox. 10 (1997) 181-188.
21. 32P-postlabelling, Carcinogenesis 16 (1995) 613-617.
22. [22] M. Arand, R. Mühlbauer, J. Hengstler, E. Jager, J. Fuchs, L. Winkler, F. Oesch, A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms, Anal. Biochem. 236 (1996) 184-186.
23. [23] E.A. Rosvold, K.A. McGlynn, E.D. Lustbader, K.H. Buetow, Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking, Pharmacogenetics 5 (1995) 199-206.
24. [24] B. Singer, B. Hang, What structural features determine repair enzyme specificity and mechanism in chemically modified DNA, Chem. Res. Tox. 10 (1997) 713-732.
25. [25] D.A. Bell, J.A. Taylor, D.F. Paulson, C.N. Robertson, J.L. Mohler, G.W. Lucier, Genetic risk and carcinogen exposure: a common inherited effect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer, J. Natl. Cancer Inst. 85 (1993) 1159-1164.
26. [26] K. Berhane, M. Widersten, Å. Engstrom, J.W. Kozarich, B. Mannervik, Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases, Proc. Natl. Acad. Sci. U.S.A. (1994) 1480-1484.
27. [27] H. Bartsch, C. Malaveille, A.B. Lowenfels, P. Maisonneuve, A. Hautefeuille, the International Pancreatic Disease Study Group, Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk, Europ. J. Cancer 7 (1998).